Literature DB >> 9747736

Antiviral activity of bovine collectins against rotaviruses.

P C Reading1, U Holmskov, E M Anders.   

Abstract

The antiviral activity against rotaviruses of three bovine collectins, conglutinin, collectin-43 (CL-43) and bovine SP-D, was examined. As shown by ELISA and Western blot, all three collectins bound to the Nebraska calf diarrhoea virus bovine strain of rotavirus, and specifically to the VP7 glycoprotein. Inhibition by mannose or EDTA confirmed that binding was mediated through the lectin domains of the collectins. Binding resulted in haemagglutination inhibition and neutralization of rotavirus infectivity, CL-43 displaying the highest activity in both types of assay. In contrast, conglutinin was the most potent of the three collectins against influenza virus A/HKx31. Neutralization of rotaviruses by the lectins was dependent on glycosylation of VP7. Furthermore, rotaviruses adapted to growth in Madin-Darby bovine kidney cells, and thus bearing carbohydrate of bovine origin, remained sensitive to neutralization, although slightly less so than virus stocks propagated in the monkey kidney cell line MA104. These findings provide the first description of antiviral activity of collectins against a non-enveloped virus and may indicate a potential role for collectins in host defence against bovine rotavirus infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9747736     DOI: 10.1099/0022-1317-79-9-2255

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  16 in total

Review 1.  Collectins and cationic antimicrobial peptides of the respiratory epithelia.

Authors:  B Grubor; D K Meyerholz; M R Ackermann
Journal:  Vet Pathol       Date:  2006-09       Impact factor: 2.221

2.  Implications of the innate immune response to adenovirus and adenoviral vectors.

Authors:  Seth M Gregory; Shoab A Nazir; Jordan P Metcalf
Journal:  Future Virol       Date:  2011-03       Impact factor: 1.831

3.  Mutagenesis of surfactant protein D informed by evolution and x-ray crystallography enhances defenses against influenza A virus in vivo.

Authors:  Erika Crouch; Nikolaos Nikolaidis; Francis X McCormack; Barbara McDonald; Kimberly Allen; Michael J Rynkiewicz; Tanya M Cafarella; Mitchell White; Kara Lewnard; Nancy Leymarie; Joseph Zaia; Barbara A Seaton; Kevan L Hartshorn
Journal:  J Biol Chem       Date:  2011-09-30       Impact factor: 5.157

4.  Distinctive anti-influenza properties of recombinant collectin 43.

Authors:  Kevan L Hartshorn; Uffe Holmskov; Soren Hansen; Pengnian Zhang; Joseph Meschi; Tirsit Mogues; Mitchell R White; Erika C Crouch
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

5.  Recognition of mannosylated ligands and influenza A virus by human surfactant protein D: contributions of an extended site and residue 343.

Authors:  Erika Crouch; Kevan Hartshorn; Tim Horlacher; Barbara McDonald; Kelly Smith; Tanya Cafarella; Barbara Seaton; Peter H Seeberger; James Head
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

6.  An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive Immunity.

Authors:  Annapurna Nayak; Eswari Dodagatta-Marri; Anthony George Tsolaki; Uday Kishore
Journal:  Front Immunol       Date:  2012-06-07       Impact factor: 7.561

Review 7.  Soluble host defense lectins in innate immunity to influenza virus.

Authors:  Wy Ching Ng; Michelle D Tate; Andrew G Brooks; Patrick C Reading
Journal:  J Biomed Biotechnol       Date:  2012-05-16

Review 8.  Surfactant protein-D and pulmonary host defense.

Authors:  E C Crouch
Journal:  Respir Res       Date:  2000-08-25

Review 9.  Lipid-Protein and Protein-Protein Interactions in the Pulmonary Surfactant System and Their Role in Lung Homeostasis.

Authors:  Olga Cañadas; Bárbara Olmeda; Alejandro Alonso; Jesús Pérez-Gil
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

Review 10.  Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future.

Authors:  Souvik Ghosh; Yashpal Singh Malik; Nobumichi Kobayashi
Journal:  Curr Drug Metab       Date:  2018       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.